Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Effective Interest Rate on Debt % : 5.78% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Takeda Pharmaceutical Co's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was $1,849 Mil. Takeda Pharmaceutical Co's average total debt for the quarter that ended in Dec. 2023 was $32,022 Mil. Therefore, Takeda Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 5.78%.

Takeda Pharmaceutical Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Takeda Pharmaceutical Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Effective Interest Rate on Debt % Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

1.42

2.79

2.68

2.60

2.52

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															7.29	-0.91	5.08	4.81	5.78

Competitive Comparison of Takeda Pharmaceutical Co's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Effective Interest Rate on Debt % falls into.

Takeda Pharmaceutical Co Effective Interest Rate on Debt % Calculation

Takeda Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Mar. 2022 )	+	Total Debt (A: Mar. 2023 ))	/ count )
=	-1 * -875.125	/	( (36646.199	+	32786.174)	/ 2 )
=	-1 * -875.125	/	34716.1865
=	2.52 %

where

	Total Debt (A: Mar. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	34925.863	+	1720.336
=	36646.199

	Total Debt (A: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	30245.481	+	2540.693
=	32786.174

Takeda Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2023 )	+	Total Debt (Q: Dec. 2023 ))	/ count )
=	-1 * -1849.348	/	( (31649.39	+	32394.19)	/ 2 )
=	-1 * -1849.348	/	32021.79
=	5.78 %

where

	Total Debt (Q: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	29790.409	+	1858.981
=	31649.39

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	29822.387	+	2571.803
=	32394.19

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Takeda Pharmaceutical Co (NYSE:TAK) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Takeda Pharmaceutical Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.